Experience with high dose intravenous immunoglobulins and topical conservative approach in the treatment of TEN
β Scribed by M. Stella; A. Clemente; E. Gangemi; E. Zingarelli; M. Cairo; C. Primiceri; C. Castagnoli
- Book ID
- 116329951
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 195 KB
- Volume
- 33
- Category
- Article
- ISSN
- 0305-4179
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
In children infected with human immunodeficiency virus (HIV) placebo-controlled trials with intravenous immunoglobulins have resulted in a significant reduction in morbidity; however, the results of small trials in adolescents and adults have been inconsistent. In this study 17 HIV-infected hemophil
## Abstract There are few reports of the use of high-dose intravenous immunoglobulin (hdIVIg) in the treatment of atopic dermatitis (AD). We describe our experience using this therapy in three patients with severe AD, all of whom had steroid-related side-effects. These patients received either Alph
The effect of intravenous immunoglobulin (IVIG) on various laboratory values was measured immediately before and after completion of serial monthly infusions of IVIG (2 g/kg) or an equal volume of placebo over 3-12 months, in 46 patients with neuromuscular diseases participating in controlled trials